You just read:

Amplyx Pharmaceuticals Initiates Dosing in Phase 1 Clinical Trial of APX001, a Novel Antifungal Product Candidate for Treatment of Life-Threatening Infections

News provided by

Amplyx Pharmaceuticals

12 Sep, 2016, 08:00 ET